Pilot study evaluating intravenous amoxicillin-clavulanate as an alternative to piperacillin-tazobactam for general surgery patients.

Antimicrob Steward Healthc Epidemiol

Department of Medicine, Alberta Health Services, Calgary, Alberta, Canada.

Published: March 2023

In this point-prevalence survey followed by prospective audit and feedback at 4 tertiary-care hospitals in Calgary, Alberta, Canada, we evaluated whether intravenous amoxicillin-clavulanate may be used as a narrower-spectrum alternative to intravenous piperacillin-tazobactam for patients admitted to general surgery services.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028943PMC
http://dx.doi.org/10.1017/ash.2023.133DOI Listing

Publication Analysis

Top Keywords

intravenous amoxicillin-clavulanate
8
general surgery
8
pilot study
4
study evaluating
4
evaluating intravenous
4
amoxicillin-clavulanate alternative
4
alternative piperacillin-tazobactam
4
piperacillin-tazobactam general
4
surgery patients
4
patients point-prevalence
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!